[Idiopathic calcium nephrolithiasis: therapeutic aspects]

Area of Science:

• Nephrology
• Urology
• Biochemistry

Context:

• Idiopathic calcium urolithiasis affects a significant portion of renal stone formers.
• Many patients exhibit underlying biochemical abnormalities, including hypercalciuria, hyperuricosuria, or hyperoxaluria.
• High fluid intake is a primary therapeutic strategy, but identifying specific metabolic disturbances enables targeted interventions.

Purpose:

• To outline a tailored therapeutic approach for idiopathic calcium urolithiasis based on specific biochemical profiles.
• To highlight the importance of accurate patient screening for effective treatment selection.
• To discuss management strategies for various forms of idiopathic hypercalciuria and hyperuricosuria.

Summary:

• A significant majority of idiopathic renal stone formers present with detectable biochemical disorders.
• Treatment strategies vary based on the specific metabolic disturbance: absorptive hypercalciuria (dietary modification, orthophosphates, thiazides), renal hypercalciuria (chlorthalidone, allopurinol), dietary hypercalciuria (dietary balance), and isolated hyperuricosuria (allopurinol).
• The efficacy of treatment is linked to precise patient stratification and screening prior to intervention.

Impact:

• This personalized approach optimizes treatment efficacy for idiopathic stone formers.
• Improved patient outcomes are expected through targeted therapies addressing specific biochemical imbalances.
• The findings underscore the necessity of comprehensive biochemical evaluation in managing recurrent kidney stones.